At Capstan Medical, we’re driven by an unwavering commitment to transforming the treatment of structural heart disease. By merging surgical robotics with catheter-based technology and next generation implants, we’ve pioneered a patient-optimized approach to repair and replace heart valves.
Location: United States, California, Santa Cruz
Employees: 11-50
Total raised: $110M
Investors 1
| Date | Name | Website |
| 04.11.2023 | Yu Galaxy | yugalaxy.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.12.2024 | Series C | $110M | - |
Mentions in press and media 16
| Date | Title | Description |
| 11.03.2025 | The Surge of Surgical Robotics: A New Era in Medicine | Surgical robotics is no longer a futuristic dream. It’s here, reshaping the landscape of medicine. The rise of robotic systems is akin to the dawn of a new age in surgery. With precision and innovation, these machines are transforming how s... |
| 10.03.2025 | 10 surgical robotics companies you need to know | MassDevice’s Surgical Robotics Special Report includes a ranking of companies based on how much money they’ve raised. Download it for free to find out the amounts. Intuitive remains the dominant surgical robotics company — but other compani... |
| 06.03.2025 | Capstan Medical completes first robot-assisted transcatheter mitral valve replacements | Capstan Medical says a surgeon has conducted the first successful catheter-delivered mitral valve replacement using the company’s nitinol-enabled implant and robotics platform. [Photo courtesy of Capstan Medical]Capstan Medical today announ... |
| 14.12.2024 | Capstan Medical: $110 Million (Series C) Raised To Advance Robotic-Enabled Minimally Invasive Solutions For Addressing Heart Valve Disease | Capstan Medical – a developer of robotic-enabled minimally invasive solutions to address heart valve disease – announced the closing of an oversubscribed $110 million Series C to advance its mission of bringing its innovative structural hea... |
| 12.12.2024 | Capstan Medical's $110 Million Leap: A New Era for Heart Valve Treatment | Capstan Medical is on the brink of a revolution. With a recent $110 million infusion from a Series C funding round, the company is poised to change the landscape of heart valve treatment. This funding, led by Eclipse and supported by existi... |
| 12.12.2024 | Capstan Medical Raises $110M in Series C Funding | Capstan Medical, a Santa Cruz, CA-based developer of robotic-enabled minimally invasive solutions to address heart valve disease, raised $110M in Series C funding. The round was led by Eclipse, with participation from existing investors Yu ... |
| 12.12.2024 | Legion Technologies Receives $50M in Financing from Silicon Valley Bank | Legion Technologies, a Santa Clara, CA-based company which specializes in workforce management (WFM), received $50M in financing from Silicon Valley Bank (SVB), a division of First Citizens Bank. The company intends to use the funds to expa... |
| 11.12.2024 | Capstan Medical Raises $110M to Advance Minimally Invasive Heart Valve Treatment | What You Should Know: – Capstan Medical, a medical technology company developing innovative solutions for heart valve disease secures $110M in a Series C funding round led by Eclipse with participation from existing investors Yu Galaxy and ... |
| 11.12.2024 | Capstan Medical Secures $110M Series C Funding | SANTA CRUZ, CA, Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced the successful closing of an oversubscribed $110 million Series C. >> Click here for more funding ... |
| 11.12.2024 | Capstan Medical raises $110M in Series C round ahead of structural heart robot’s first-in-human procedure | Capstan Medical is developing a robotics platform and catheter-delivered heart implants for mitral and tricuspid valve replacements. [Photo courtesy of Capstan Medical]Capstan Medical has raised $110 million in new funding from an oversubsc... |
Show more